<?xml version='1.0' encoding='utf-8'?>
<document id="24390929"><sentence text="Analysis of potential drug-drug interactions in medical intensive care unit patients." /><sentence text="To describe the frequency and type of potential drug-drug interactions (pDDIs) in a general intensive care unit (ICU) and to make recommendations to improve the management of these pDDIs" /><sentence text="" /><sentence text="Retrospective observational study" /><sentence text="" /><sentence text="General ICU of a tertiary care hospital" /><sentence text="" /><sentence text="All patients admitted for more than 24Â hours between May 2009 and December 2010 who were prescribed at least one medication" /><sentence text="" /><sentence text="Based on the G-Standaard, the Dutch national drug database, pDDIs were identified and classified into categories of potential clinical outcome and management advice" /><sentence text=" In total, 35,784 medication episodes were identified, resulting in 2887 pDDIs (8" /><sentence text="1%)" /><sentence text=" These 2887 pDDIs occurred in 1659 patients for a mean frequency of 1" /><sentence text="7 (95% confidence interval [CI] 1" /><sentence text="6-1" /><sentence text="9) pDDIs per patient" /><sentence text=" Overall, 54% of the patients experienced at least one pDDI with pDDIs present during 27% of all ICU admission days" /><sentence text=" All pDDIs could be reconstructed using 81 of the 358 (23%) relevant unique pDDI pairs described in the G-Standaard" /><sentence text=" The most frequently occurring potential clinical consequence was an increased risk of side effects or toxicity (91% of the pDDIs) such as electrolyte disturbances and masking of hypoglycemia" /><sentence text=" The most important advised management strategy was monitoring (81%), consisting of monitoring of laboratory values (52%), clinical monitoring of toxicity or effectiveness (48%), or monitoring of physical parameters such as electrocardiogram and blood pressure (11%)" /><sentence text="" /><sentence text="Potential drug-drug interactions occur in 54% of all ICU patients, which is two times more than the rate seen in patients on general wards" /><sentence text=" A limited set of 20 pDDI pairs is responsible for more than 90% of all pDDIs" /><sentence text=" Therefore, it is worthwhile to develop guidelines for the management of these specific pDDIs" /><sentence text=" As the vast majority of the interactions can be managed by monitoring, advanced clinical decision support systems linking laboratory data to prescription data may be an effective risk management strategy" /><sentence text="" /></document>